Welcome to NewPressRelease.com a free press release service. Publishing press releases for Public Relations never been easier. Just register (it's free and it takes less then a 1 minute) then use Submit Press Release. Our services aim to help you reach journalists and to improve visibility in search engine listings, so you can get the most publicity possible.

The Cancer Market Outlook to 2015: Competitive landscape, market size, pipeline analysis, and growth opportunities

Health and Fitness

(Free Press Release) Bharatbook.com has added this latest report The Cancer Market Outlook to 2015: Competitive landscape, market size, pipeline analysis, and growth opportunities to their extensive collection of market research reports. Global cancer prevalence rates are on the rise owing to an aging population, changing lifestyle and increasing pollution.

The Cancer Market Outlook to 2015: Competitive landscape, market size, pipeline analysis, and growth opportunities


       Normal 0 false false false MicrosoftInternetExplorer4 /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Times New Roman"; mso-ansi-language:#0400; mso-fareast-language:#0400; mso-bidi-language:#0400;}

Bharatbook.com has added this latest report " The Cancer Market Outlook to 2015: Competitive landscape, market size, pipeline analysis, and growth opportunities" to their extensive collection of market research reports. Global cancer prevalence rates are on the rise owing to an aging population, changing lifestyle and increasing pollution. Prevalence data is significantly influenced by the increasing diagnosis and survival rates across the global market.

The global cancer market is becoming increasingly competitive, with two therapeutic classes namely antineoplastics and cytostatic hormonal treatments dominating this sector. Collectively, the top 10 products in the global cancer market accounted for majority of the revenue in 2009.

Oncology has become one of the major focus areas for pharmaceutical and biotechnology companies because of a high number of unmet needs for improved treatments in different types of cancer. In 2009, around 40,000 Phase I, II and III trials were listed on ClinicalTrials.gov, and approximately 40% of these were related to cancer.

Targeted therapies are revolutionizing the paradigm of cancer treatment and are likely to be used in most cancer patients in the next 10 years. Due to the high incidence and subsequent potential for market success, breast cancer and NSCLC continue to drive high levels of R&D (along with niche indications such as NHL, RCC, CML, and prostate cancer).

Another factor that plays a major role for the growth in the cancer therapy market is expansion of the target indications. Most of the blockbuster drugs were launched for a narrow indication, and were later approved for other indications. A classic example is imatinib, which was first approved by the FDA in 2001 for the treatment of CML and later was expanded to around nine different indications.

Regardless of indication, the key challenge in ensuring the commercial success of pipeline drugs is to ascertain their integration into current treatment regimens either in combination with existing therapies or by demonstrating significant superiority over current treatments. Pricing risk remains the key investment concern in cancer. Moreover, the level of scrutiny by payors regarding the cost-effectiveness of cancer treatments has further intensified in the recent years.

Key Features of this report

• Epidemiological analysis and forecast prevalence of the major cancer indications between 2009-15 including lung, breast, colorectal, and ovarian cancer markets.

• Forecasts and analysis of the major products in the cancer market between 2009-15 spread across the major indications and classes of treatments.

• Overview of key events in the global cancer market that have impacted treatment trends and sales potential across the major cancer indications.

• Strategic and growth analysis of leading pharmaceutical corporations based on sales focus by drug class, currently marketed products and R&D product portfolios.

• Detailed analysis across major classes of cancer treatments including antineoplastics and cytotoxic hormone therapies.

• Detailed analysis of the clinically differentiated products in the cancer pipeline by indication and sales forecast of key R&D pipeline products in the global cancer market.

Key Benefits of this report

• Develop insight into patient potential with the report’s coverage of major indications in the cancer segment, the seven largest geographic pharmaceutical markets and the 10 largest companies active in the cancer segment today

• Understand how recent events are affecting the performance of major products, and how their marketers are confronting competitive changes in the cancer marketplace

• Gain up-to-date competitive intelligence across the cancer indications and understand the major issues affecting key pharmaceutical/biotech players

• Understand which indications have the greatest potential to provide franchise growth, and how pharmaceutical companies are attempting to exploit these opportunities

• Compare the franchises of top pharmaceutical marketers across major indications, and understand how market share of leading companies will change over the next 6 years

• Use head-to head comparisons of the leading cancer pipeline compounds to understand which companies will have a presence among key indications over the next 6 years


For more information kindly visit: http://www.bharatbook.com/detail.asp?id=130209&rt=The-Cancer-Market-Outlook-to-2015-Competitive-landscape-market-size-pipeline-analysis-and-growth-opportunities.html

Related Reports:

Prostate Cancer - Pipeline Assessment and Market Forecasts to 2020
http://www.bharatbook.com/detail.asp?id=166013&rt=Prostate-Cancer-Pipeline-Assessment-and-Market-Forecasts-to-2020.html

Ubiquitin Proteosome Drugs: Cancer and Neurodegenerative Disorder Markets
http://www.bharatbook.com/detail.asp?id=146062&rt=Ubiquitin-Proteosome-Drugs-Cancer-and-Neurodegenerative-Disorder-Markets.html

Or

Contact us at :

Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Website: www.bharatbook.com
Follow us on twitter: http://twitter.com/3bbharatbook
Please visit our blog at http://bharatresearch.wordpress.com




The Cancer Market Outlook to 2015: Competitive landscape, market size, pipeline analysis, and growth opportunities

Source: Press Release

---------------------------

Disclaimer

If you have any questions regarding information in this press release, please contact the person listed as the Author or use the contact informations published in the press release. Please do not attempt to contact NewPressRelease.com. We are unable to assist you with any information regarding this release. NewPressRelease.com disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.

Related Items

All press release information on this site, including free press releases, is solely based on what our users submit. NewPressRelease.com disclaims that any right and responsibility for the information goes to the user who submit the press release. Some press release may be confusing without additional explanation. You should contact the provider with any questions about the information presented. In case some press release damages your benefits or violate your rights in any way, please contact us and we'll remove it immediately.


Copyright © 2008 - 2018 Free Press Release by NewPressRelease.com